ARBY COHEN: Open Payments
NPI 1871118570 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 59 payments from 15 companies in 2025. Trend: 2023 $5,779 · 2024 $4,211 · 2025 $1,293
Food & beverage: $1,193Education: $100
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 34 | $410 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $161 |
| Eisai Inc. | 2 | $147 |
| Astellas Pharma US Inc | 1 | $122 |
| SEAGEN INC. | 1 | $100 |
| Janssen Biotech, Inc. | 3 | $83 |
| PFIZER INC. | 2 | $55 |
| Daiichi Sankyo Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
Products named: CABOMETYX, Padcev, Lenvima, Nubeqa, ERLEADA, LYNPARZA, Enhertu, Xofigo.
Industry payments across TX — which companies pay providers there.
